Elenco Pubblicazioni

Elenco pubblicazioni

1. Bordi C, Falchetti A, Azzoni C, D'Adda T, Morelli A, Peracchia A, Brandi ML. Lack of allelic loss at the multiple endocrine neoplasia type 1 (MEN-1) gene locus in a pancreatic ductal (non-endocrine) adenocarcinoma of a patient with the MEN-1 syndrome. Virchows Arch. 1995;426(2):203-8.
2. Morelli A, Falchetti A, Weinstein L, Fabiani S, Tomassetti P, Enzi G, Carraro R, Bordi C, Tonelli F, Brandi ML. RFLP analysis of human chromosome 11 region q13 in multiple symmetric lipomatosis and multiple endocrine neoplasia type 1-associated lipomas. Biochem Biophys Res Commun. 1995 Feb 6;207(1):363-8.
3. Morelli A, Falchetti A, Castello R, Furlani L, Tomassetti P, Tonelli F, Frilling A, Serio M, Brandi ML. Genetic screening to identify the gene carrier in Italian and German kindreds affected by multiple endocrine neoplasia type 1 (MEN 1) syndrome. J Endocrinol Invest. 1995 May;18(5):329-35.
4. Fiorelli G, Gori F, Frediani U, Morelli A, Falchetti A, Benvenuti S, Masi L, Brandi ML. Evidence for bioeffects of LY 139478 on the human pre-osteoclastic cell line FLG 29.1. Biochem Biophys Res Commun. 1995 Jun 26;211(3):857-63.
5. Fiorelli G, Formigli L, Zecchi Orlandini S, Gori F, Falchetti A, Morelli A, Tanini A, Benvenuti S, Brandi ML. Characterization and function of the receptor for IGF-I in human preosteoclastic cells. Bone. 1996 Mar;18(3):269-76.
6. Morelli A, Falchetti A, Amorosi A, Tonelli F, Bearzi I, Ranaldi R, Tomassetti P, Brandi ML. Clonal analysis by chromosome 11 microsatellite-PCR of microdissected parathyroid tumors from MEN 1 patients. Biochem Biophys Res Commun. 1996 Oct 23;227(3):736-42.
7. Falchetti A, Morelli A, Amorosi A, Tonelli F, Fabiani S, Martineti V, Castello R, Furlani L, Brandi ML. Allelic loss in parathyroid tumors from individuals homozygous for multiple endocrine neoplasia type 1. J Clin Endocrinol Metab. 1997 Jul;82(7):2278-82.
8. Gennari L, Becherini L, Mansani R, Masi L, Falchetti A, Morelli A, Colli E, Gonnelli S, Cepollaro C, Brandi ML. FokI polymorphism at translation initiation site of the vitamin D receptor gene predicts bone mineral density and vertebral fractures in postmenopausal Italian women. J Bone Miner Res. 1999 Aug;14(8):1379-86.
9. Falchetti A, Becherini L, Martineti V, Morelli A, Benvenuti S, Picariello L, Gennari L, Lampugnani R, Bordi C, Brandi ML. Telomerase repeat amplification protocol (TRAP): A new molecular marker for parathyroid carcinoma. Biochem Biophys Res Commun. 1999 Nov;265(1):252-5.
10. Morelli A, Falchetti A, Martineti V, Becherini L, Mark M, Friedman E, Brandi ML. MEN1 gene mutation analysis in Italian patients with multiple endocrine neoplasia type 1. Eur J Endocrinol. 2000 Feb;142(2):131-7.
11. Becherini L, Gennari L, Masi L, Mansani R, Massart F, Morelli A, Falchetti A, Gonnelli S, Fiorelli G, Tanini A, Brandi ML. Evidence of a linkage disequilibrium between polymorphisms in the human estrogen receptor alpha gene and their relationship to bone mass variation in postmenopausal Italian women. Hum Mol Genet. 2000 Aug 12;9(13):2043-50.
12. Picariello L, Benvenuti S, Recenti R, Formigli L, Falchetti A, Morelli A, Masi L, Tonelli F, Cicchi P, Brandi ML. Microencapsulation of human parathyroid cells: an "in vitro" study. J Surg Res. 2001 Mar;96(1):81-9.
13. Mark M, Morelli A, Brandi ML, Falchetti A, Olchovski D, Araldi G, Mantero F, Friedman E Somatic mutation analysis of the MEN1 gene in adrenocortical tumors using denaturing gradient gel electrophoresis (DGGE). J Endocrinol Genetics 2001 2: 21-27.
14. Morelli A, Falchetti A, Brandi ML. Gene mutations in Multiple Endocrine Neoplasia Type 1. Topical Endocrinology 2001 Issue 18: 6-9.
15. Filippi S, Marini M, Vannelli GB, Crescioli C, Granchi S, Vignozzi L, Luconi M, Ferruzzi P, Morelli A, Forti G, Ledda F, Maggi M. Effects of hypoxia on endothelin-1 sensitivity in the corpus cavernosum. Mol Hum Reprod. 2003 Dec;9(12):765-74.
16. Vignozzi L, Filippi S, Luconi M, Morelli A, Mancina R, Marini M, Vannelli GB, Granchi S, Orlando C, Gelmini S, Ledda F, Forti G, Maggi M. Oxytocin receptor is expressed in the penis and mediates an estrogen-dependent smooth muscle contractility. Endocrinology. 2004 Apr;145(4):1823-34.
17. Morelli A, Filippi S, Mancina R, Luconi M, Vignozzi L, Marini M, Orlando C, Vannelli GB, Aversa A, Natali A, Forti G, Giorgi M, Jannini EA, Ledda F, Maggi M. Androgens regulate phosphodiesterase type 5 expression and functional activity in corpora cavernosa. Endocrinology. 2004 May;145(5):2253-63.
18. Crescioli C, Morelli A, Adorini L, Ferruzzi P, Luconi M, Vannelli GB, Marini M, Gelmini S, Fibbi B, Donati S, Villari D, Forti G, Colli E, Andersson KE, Maggi M. Human bladder as a novel target for vitamin D receptor ligands. J Clin Endocrinol Metab. 2005 Feb;90(2):962-72.
19. Vignozzi L, Vannelli GB, Morelli A, Mancina R, Marini M, Ferruzzi P, Crescioli C, Luconi M, Donati S, Fisher AD, Baldi E, Filippi S, Forti G, Maggi M. Identification, characterization and biological activity of oxytocin receptor in the developing human penis. Mol Hum Reprod. 2005 Feb;11(2):99-106.
20. Mancina R, Filippi S, Marini M, Morelli A, Vignozzi L, Salonia A, Montorsi F, Mondaini N, Vannelli GB, Donati S, Lotti F, Forti G, Maggi M. Expression and functional activity of phosphodiesterase type 5 in human and rabbit vas deferens. Mol Hum Reprod. 2005 Feb;11(2):107-15.
21. Zhang XH, Morelli A, Luconi M, Vignozzi L, Filippi S, Marini M, Vannelli GB, Mancina R, Forti G, Maggi M. Testosterone regulates PDE5 expression and in vivo responsiveness to tadalafil in rat corpus cavernosum. Eur Urol. 2005 Mar;47(3):409-16.
22. Zhang XH, Filippi S, Vignozzi L, Morelli A, Mancina R, Luconi M, Donati S,Marini M, Vannelli GB, Forti G, Maggi M. Identification, localization and functional in vitro and in vivo activity of oxytocin receptor in the rat penis. J Endocrinol. 2005 Mar;184(3):567-76.
23. Vignozzi L, Corona G, Petrone L, Filippi S, Morelli A, Forti G, Maggi M. Testosterone and sexual activity. J. Endocrinol. Invest., 2005, 28(3 Suppl):39-44.
24. Romanelli RG, Barni T, Maggi M, Luconi M, Failli P, Pezzatini A, Morelli A, Maggi R, Zaninetti R, Salerno R, Ambrosiani, S, Marini M, Rotella CM, Vannelli GB. Role of endothelin-1 in the migration of human olfactory gonadotropin-releasing hormone-secreting neuroblasts. Endocrinology. 2005 Oct;146(10):4321-30.
25. Filippi S, Morelli A, Vignozzi L, Vannelli GB, Marini M, Ferruzzi P, Mancina R, Crescioli C, Mondaini N, Forti G, Ledda F, Maggi M. Oxytocin mediates the estrogen-dependent contractile activity of endothelin-1 in human and rabbit epididymis Endocrinology 2005, Aug;146(8):3506-17.
26. Morelli A, Vignozzi L, Filippi S, Mancina R, Maggi M. Erectile dysfunction: molecular biology, pathophysiology and pharmacological treatment. Minerva Urol Nefrol. 2005 Jun;57(2):85-90.
27. Zhang XH, Filippi S, Morelli A, Vignozzi L, Luconi M, Donati S, Forti G, Maggi M. Testosterone restores diabetes-induced erectile dysfunction and sildenafil responsiveness in two distinct animal models of chemical diabetes. J Sex Med. 2006 Mar;3(2):253-64.
28. Vignozzi L, Filippi S, Morelli A, Ambrosini S, Luconi M, Vannelli GB, Donati S, Crescioli C, Zhang XH, Mirone V, Forti G, Maggi M. Effect of chronic tadalafil administration on penile hypoxia induced by cavernous neurotomy in the rat. J Sex Med. 2006 May;3(3):419-31.
29. Morelli A., Filippi S., Vignozzi L., Mancina R. & Maggi M. Physiology of erectile function: an update on intracellular molecular processes EAU-EBU Update Series, 4: 96-108, 2006.
30. Krausz C, Degl'Innocenti S, Nuti F, Morelli A, Felici F, Sansone M, Variale G, Forti G. Natural transmission of USP9Y gene mutations: a new perspective on the role of AZFa genes in male fertility. Hum Mol Genet. 2006 Sep 15;15(18):2673-81.
31. Maggi M, Crescioli C, Morelli A, Colli E, Adorini L. Pre-clinical evidence and clinical translation of benign prostatic hyperplasia treatment by the vitamin D receptor agonist BXL-628 (Elocalcitol). J Endocrinol Invest. 2006 Jul-Aug;29(7):665-74.
32. Morelli A, Filippi S, Zhang XH, Luconi M, Vignozzi L, Mancina R, Maggi M. Peripheral regulatory mechanisms in erection. Inter. J. Androl. 2005, Dec;28 Suppl 2:23-27.
33. Morelli A, Vignozzi L, Filippi S, Vannelli GB, ambrosiani S, Mancina R, Crescioli C, Donati S, Fibbi B, Colli E, Adorini L, Maggi M. BXL-628, a Vitamin D Receptor Agonist Effective in Benign Prostatic Hyperplasia Treatment, Prevents RhoA Activation and Inhibits RhoA/Rho Kinase Signalling in Rat and Human Bladder. Prostate, 2007; 67(3):234-47.
34. Filippi S, Morelli A, Sandner P, Fibbi B, Mancina R, Marini M, Gacci M, Vignozzi L, Vannelli GB, Carini M, Forti G, Maggi M. Characterization and functional role of androgen-dependent PDE5 activity in the bladder. Endocrinology. 2007;148(3):1019-29.
35. Vignozzi L, Morelli A, Filippi S, Ambrosini S, Mancina R, Luconi M, Mungai S, Vannelli GB, Zhang XH, Forti G, Maggi M. Testosterone regulates RhoA/Rho-kinase signalling in two distinct animal models of chemical diabetes. J Sex Med. 2007 May;4(3):620-30.
36. Fibbi B, Morelli A, Marini M, Zhang XH, Mancina R, Vignozzi L, Filippi S, Chavalmane A, Silvestrini E, Colli E, Adorini L, Vannelli GB, Maggi M. Atorvastatin but not elocalcitol increases sildenafil responsiveness in Spontaneously Hypertensive Rats by regulating the RhoA/ROCK pathway. J Androl. 2008 Jan-Feb;29(1):70-84.
37. Vignozzi L, Morelli A, Filippi S, Vannelli GB, Mungai S, Marini M, Boddi V, Forti G, Maggi M. Effect of sildenafil administration on penile hypoxia induced by cavernous neurotomy in the rat. Int J Impot Res. 2008 Jan-Feb;20(1):60-7.
38. Adorini L, Penna G, Amuchastegui S, Cossetti C, Aquilano F, Mariani R, Fibbi B, Morelli A, Uskokovic M, Colli E, Maggi M. Inhibition of prostate growth and inflammation by the vitamin D receptor agonist BXL-628 (elocalcitol). J Steroid Biochem Mol Biol. 2007 Mar;103(3-5):689-93.
39. Morelli A, Corona G, Vignozzi L, Filippi S, Forti G, Maggi M. Which patients with sexual dysfunction are suitable for testosterone replacement therapy? J Endocrinol Invest, 2007 Nov;30(10):880-8.
40. Morelli A, Marini M, Mancina R, Luconi M, Vignozzi L, Fibbi B, Filippi S, Pezzatini A, Forti G, Vannelli GB, Maggi M. Sex steroids and leptin regulate the “first kiss” (KiSS 1/GPR54 system) in human GnRH-secreting neuroblasts. J Sex Med 2008 Mar 4, 5(5):1097-113.
41. Morelli A, Squecco R, Failli P, Filippi S, Vignozzi L, Chavalmane AK, Fibbi B, Mancina R, Luciani G, Gacci M, Colli E, Francini F, Adorini L, Maggi M. The vitamin D receptor agonist elocalcitol up-regulates L-type calcium channel activity in human and rat bladder. Am J Physiol Cell Physiol. 2008 Mar 19; 294(5):C1206-14.
42. Vignozzi L, Filippi S, Morelli A, Luconi M, Forti G, Maggi M. Regulation of epididymal contactility during semen emission, the first part of the ejaculatory process: a role for estrogen. J Sex Med, 2008 Sep; 5(9):2010-6.
43. Vignozzi L, Morelli A. Editorial Comment on: Intravesical Botulinum Toxin A Administration Inhibits COX-2 and EP4 Expression and Suppresses Bladder Hyperactivity in Cyclophosphamide-Induced Cystitis in Rats. Eur Urol. 2008 May 20. [Epub ahead of print]
44. Morelli A , Chavalmane AK, Filippi S, Fibbi B, Silvestrini E, Sarchielli E, Zhang XH, Vignozzi L, Vannelli GB, Forti G, Maggi M. Atorvastatin ameliorates sildenafil-induced penile erections in experimental diabetes by inhibiting diabetes-induced RhoA/Rho-kinase signalling hyper-activation. J Sex Med, 2009 Jan;6(1):91-106.
45. Morelli A, Fibbi B, Marini M, Silvestrini E, De Vita G, Chavalmane AK, Vignozzi L, Filippi S, Forti G, Vannelli GB, Maggi M. Dihydrotestosterone and leptin regulate gonadotropin-releasing hormone (GnRH) expression and secretion in human GnRH-secreting neuroblasts. J Sex Med, 2009 Feb;6(2):397-407
46. Carosa E, Rossi S, Giansante N, Gravina GL, Castri A, Dolci S, Botti F, Morelli A, Di Luigi L, Pepe M, Lenzi A, Jannini EA. The ontogenetic expression pattern of type 5 phosphodiesterase correlates with androgen receptor expression in rat corpora cavernosa. J Sex Med, 2009 Feb;6(2):388-96.
47. Vignozzi L, Filippi S, Morelli A, Marini M, Chavalmane A, Fibbi B, Silvestrini E, Mancina R, Carini M, Vannelli GB, Forti G, Maggi M. Cavernous neurotomy in the rat is associated with the onset of an overt condition of hypogonadism. J Sex Med. 2009 May;6(5):1270-83.
48. Fibbi B, Filippi S, Morelli A, Vignozzi L, Silvestrini E, Chavalmane A, De Vita G, Marini M, Gacci M, Manieri C, Vannelli GB, Maggi M. Estrogens regulate humans and rabbit epididymal contractility through the RhoA/Rho-kinase pathway. J Sex Med. 2009 Aug;6(8):2173-86.
49. Morelli A, Filippi S, Sandner P, Fibbi B, Chavalmane AK, Silvestrini E, Sarchielli E, Vignozzi L, Gacci M, Carini M, Vannelli GB, Maggi M. Vardenafil modulates bladder contractility through cGMP-mediated inhibition of RhoA/Rho kinase signaling pathway in spontaneously hypertensive rats. J Sex Med. 2009 Jun;6(6):1594-608.
50. Fibbi B, Penna G, Morelli A, Adorini L, Maggi M. Chronic inflammation in the pathogenesis of benign prostatic hyperplasia. Int J Androl. 2009 Jun 8. [Epub ahead of print].
51. Filippi S, Vignozzi L, Morelli A, Chavalmane AK, Sarchielli E, Fibbi B, Saad F, Sandner P, Ruggiano P, Vannelli GB, Mannucci E, Maggi M. Testosterone Partially Ameliorates Metabolic Profile and Erectile Responsiveness to PDE5 Inhibitors in an Animal Model of Male Metabolic Syndrome. J Sex Med. 2009 Sep 1. [Epub ahead of print],
52. Fibbi B, Morelli A, Vignozzi L, Filippi S, Chavalmane A, De Vita G, Marini M, Gacci M, Vannelli GB, Sandner P, Maggi M. Characterization of Phosphodiesterase Type 5 Expression and Functional Activity in the Human Male Lower Urinary Tract. J Sex Med. 2009 Sep 29. [Epub ahead of print].
53. Morelli A, Filippi S, Comeglio P, Sarchielli E, Chavalmane AK, Vignozzi L, Fibbi B, Silvestrini E, Sandner P, Gacci M, Carini M, Vannelli GB, Maggi M. Acute Vardenafil Administration Improves Bladder Oxygenation in Spontaneously Hypertensive Rats. J Sex Med. 2009 Nov 3. [Epub ahead of print].